Physician
El Camino Pathology Medical Group, INC
El Camino Pathology Medical Group, INC was paid $132K by Medicaid between Jan 2018 and Oct 2024, across 69 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 21% of everything it billed.
33Billing provider infoEL CAMINO PATHOLOGY MEDICAL GROUP, INC
MOUNTAIN VIEW, CA 94040
MOUNTAIN VIEW, CA 94040
33aNPI1922185636assigned 11/01/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$132K
24GClaims216,587
24DCodes billed69
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in California
Rank by total paid#90 of 222
Median peer was paid$42K
This provider vs. median3.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,419 | $19K | |
| 2019 | 26,533 | $22K | |
| 2020 | 26,801 | $36K | |
| 2021 | 36,640 | $26K | |
| 2022 | 30,398 | $10K | |
| 2023 | 35,338 | $12K | |
| 2024incomplete | 33,458 | $7K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 21% | 1,760 | 1,640 | $28K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 20% | 1,538 | 1,491 | $27K |
| 80053 | Comprehensive metabolic panel | 11% | 33,459 | 24,301 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.7% | 39,658 | 26,183 | $12K |
| 84484 | 2.5% | 9,342 | 8,067 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2.4% | 1,385 | 1,340 | $3K |
| 83690 | 2.4% | 10,256 | 9,098 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.3% | 4,386 | 3,908 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.0% | 7,344 | 6,740 | $3K |
| 83880 | 2.0% | 3,443 | 2,787 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.8% | 1,424 | 1,304 | $2K |
| 81001 | 1.7% | 15,738 | 14,190 | $2K |
57 more codes
| 87486 | 1.7% | 1,508 | $2K | |
| 87581 | 1.7% | 1,506 | $2K | |
| 87040 | 1.4% | 3,532 | $2K | |
| 83735 | 1.2% | 10,716 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 1,787 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.1% | 9,598 | $1K |
| 88342 | 1.0% | 110 | $1K | |
| 84145 | 1.0% | 1,887 | $1K | |
| 84439 | <1% | 2,867 | $1K | |
| 83605 | <1% | 3,483 | $1K | |
| 85379 | <1% | 2,470 | $1K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 280 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,791 | $947.47 |
| 87186 | <1% | 2,293 | $880.76 | |
| 87077 | <1% | 1,965 | $758.25 | |
| 85730 | <1% | 3,117 | $650.92 | |
| 80061 | Lipid panel | <1% | 1,251 | $622.11 |
| 85610 | <1% | 4,814 | $614.00 | |
| 82553 | <1% | 862 | $552.92 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,003 | $521.03 |
| 88307 | <1% | 28 | $483.06 | |
| 87081 | <1% | 2,496 | $482.54 | |
| 84702 | <1% | 721 | $460.40 | |
| 85027 | <1% | 3,912 | $437.41 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,304 | $433.78 |
| 81025 | <1% | 297 | $417.88 | |
| 86140 | <1% | 2,446 | $387.91 | |
| 86901 | <1% | 2,856 | $379.68 | |
| 86900 | <1% | 2,814 | $352.80 | |
| 86850 | <1% | 2,491 | $340.25 | |
| 84703 | <1% | 3,472 | $334.91 | |
| 82077 | <1% | 687 | $234.94 | |
| 87641 | <1% | 847 | $219.04 | |
| 80143 | <1% | 485 | $178.92 | |
| 80179 | <1% | 440 | $149.10 | |
| 87493 | <1% | 245 | $109.47 | |
| 87807 | <1% | 401 | $88.73 | |
| 85651 | <1% | 342 | $40.00 | |
| 82570 | <1% | 98 | $22.94 | |
| 82550 | <1% | 93 | $21.67 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,203 | $20.93 |
| 82728 | <1% | 98 | $20.56 | |
| 87070 | <1% | 54 | $18.30 | |
| 85652 | <1% | 274 | $17.52 | |
| 87210 | <1% | 40 | $13.06 | |
| 86780 | <1% | 44 | $12.97 | |
| 83540 | <1% | 185 | $6.40 | |
| 87147 | <1% | 29 | $6.37 | |
| 83550 | <1% | 180 | $5.24 | |
| 86308 | <1% | 54 | $5.14 | |
| 87324 | <1% | 57 | $4.84 | |
| 87449 | <1% | 60 | $4.70 | |
| 82010 | <1% | 14 | $1.18 | |
| 87205 | <1% | 16 | $0.68 | |
| 86880 | 0% | 25 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 142 | $0.00 |
| 80202 | 0% | 64 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOMBARD, CHARLES (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Caress Home Health Providers, INC. | Canoga Park, CA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.